EE03513B1 - Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid - Google Patents

Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid

Info

Publication number
EE03513B1
EE03513B1 EE9800247A EE9800247A EE03513B1 EE 03513 B1 EE03513 B1 EE 03513B1 EE 9800247 A EE9800247 A EE 9800247A EE 9800247 A EE9800247 A EE 9800247A EE 03513 B1 EE03513 B1 EE 03513B1
Authority
EE
Estonia
Prior art keywords
pct
active substances
substances containing
new combinations
antithrombotic compound
Prior art date
Application number
EE9800247A
Other languages
English (en)
Estonian (et)
Other versions
EE9800247A (et
Inventor
Bernat Andr�
Herbert Jean-Marc
Savi Pierre
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9489354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE03513(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi filed Critical Sanofi
Publication of EE9800247A publication Critical patent/EE9800247A/xx
Publication of EE03513B1 publication Critical patent/EE03513B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9800247A 1996-02-19 1997-02-17 Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid EE03513B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602027A FR2744918B1 (fr) 1996-02-19 1996-02-19 Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique
PCT/FR1997/000296 WO1997029753A1 (fr) 1996-02-19 1997-02-17 Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique

Publications (2)

Publication Number Publication Date
EE9800247A EE9800247A (et) 1999-02-15
EE03513B1 true EE03513B1 (et) 2001-10-15

Family

ID=9489354

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800247A EE03513B1 (et) 1996-02-19 1997-02-17 Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid

Country Status (29)

Country Link
US (1) US5989578A (zh)
EP (1) EP0881901B1 (zh)
JP (1) JP3662028B2 (zh)
KR (1) KR100295345B1 (zh)
CN (1) CN1116042C (zh)
AT (1) ATE218870T1 (zh)
AU (1) AU715655B2 (zh)
BR (1) BR9707556A (zh)
CA (1) CA2246289C (zh)
CZ (1) CZ292363B6 (zh)
DE (2) DE69713287T2 (zh)
DK (1) DK0881901T3 (zh)
EE (1) EE03513B1 (zh)
ES (1) ES2176684T3 (zh)
FR (1) FR2744918B1 (zh)
HK (1) HK1017850A1 (zh)
HU (1) HU225036B1 (zh)
IL (1) IL125848A (zh)
IS (1) IS1892B (zh)
NO (2) NO317747B3 (zh)
NZ (1) NZ331444A (zh)
PL (1) PL187292B1 (zh)
PT (1) PT881901E (zh)
RU (1) RU2184547C2 (zh)
SI (1) SI0881901T1 (zh)
SK (1) SK284285B6 (zh)
TR (1) TR199801608T2 (zh)
UA (1) UA51695C2 (zh)
WO (1) WO1997029753A1 (zh)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2322824A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
US6248729B1 (en) 1998-06-17 2001-06-19 Bristol-Myers Squibb Co. Combination of an ADP-receptor blocking antiplatelet drug and antihypertensive drug and a method for preventing a cerebral infarction employing such combination
US6509348B1 (en) 1998-11-03 2003-01-21 Bristol-Myers Squibb Company Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
FR2797400A1 (fr) * 1999-08-11 2001-02-16 Sanofi Synthelabo Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant
RU2262933C2 (ru) * 2000-12-25 2005-10-27 Санкио Компани, Лимитед Медицинские композиции, содержащие аспирин
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
FR2832929A1 (fr) * 2001-12-05 2003-06-06 Sanofi Synthelabo Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques
WO2004031143A2 (en) * 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
WO2005007868A2 (en) * 2003-07-08 2005-01-27 Accumetrics, Inc. Controlled platelet activation to monitor therapy of adp antagonists
US20070243632A1 (en) * 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
HUP0400982A2 (en) * 2004-05-17 2006-08-28 Chemor Kutato New veterinary product for honeybees
US20060222640A1 (en) * 2005-03-29 2006-10-05 Boehringer Ingelheim International Gmbh New pharmaceutical compositions for treatment of thrombosis
AU2006292946B2 (en) * 2005-09-21 2009-12-10 Chong Kun Dang Pharmaceutical Corp. Novel resinate complex of s-clopidogrel and production method thereof
WO2008048083A1 (es) * 2006-10-17 2008-04-24 Espinosa Abdala Leopoldo De Je Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas
DE102006051625A1 (de) 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
EP2152078B8 (en) 2007-04-27 2021-03-17 CyDex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
KR100949273B1 (ko) * 2008-02-22 2010-03-25 한올제약주식회사 복합제제
DE102008032361A1 (de) 2008-07-10 2010-01-21 Csl Behring Gmbh Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie
US8236782B2 (en) * 2009-05-13 2012-08-07 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
BRPI1009600A2 (zh) 2009-06-25 2016-03-22 Tetra S A
US8563574B2 (en) 2009-12-07 2013-10-22 Academic Pharmaceuticals, Inc. Parenteral formulation of clopidogrel
CN102389436A (zh) * 2011-09-09 2012-03-28 北京阜康仁生物制药科技有限公司 一种抗血小板聚集的药物组合物
KR101675501B1 (ko) 2011-11-02 2016-11-14 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
US8513278B2 (en) 2011-11-26 2013-08-20 Academic Pharmaceuticals, Inc. Parenteral dextrose formulation of clopidogrel
CN102406938A (zh) * 2011-11-29 2012-04-11 北京阜康仁生物制药科技有限公司 一种抗血栓的药物组合物
KR101473268B1 (ko) * 2012-03-09 2014-12-16 주식회사유한양행 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법
CN103720700A (zh) * 2012-10-10 2014-04-16 江苏威凯尔医药科技有限公司 含有阿斯匹林和维卡格雷的药用组合物
ES2657291T3 (es) 2013-04-22 2018-03-02 Csl Ltd. Un complejo covalente de factor de von Willebrand y factor VIII asociado por un puente disulfuro
KR101502588B1 (ko) 2013-05-01 2015-03-16 한국유나이티드제약 주식회사 클로피도그렐 및 아스피린의 복합제제
JP5905165B2 (ja) * 2013-08-02 2016-04-20 サノフイ アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
RU2745774C1 (ru) * 2020-08-14 2021-03-31 Алексей Викторович Марочков Способ лечения пациентов с новой коронавирусной инфекцией (covid-19)
US20230059869A1 (en) 2021-08-03 2023-02-23 Liqmeds Worldwide Limited Oral pharmaceutical solution of clopidogrel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2307538A1 (fr) * 1975-04-18 1976-11-12 Centre Etd Ind Pharma Nouveau medicament anti-agregant plaquettaire

Also Published As

Publication number Publication date
UA51695C2 (uk) 2002-12-16
IS4827A (is) 1998-08-18
KR100295345B1 (ko) 2001-08-07
SK110598A3 (en) 1999-01-11
PL187292B1 (pl) 2004-06-30
EP0881901B1 (fr) 2002-06-12
HUP9901144A2 (hu) 1999-09-28
IS1892B (is) 2003-10-20
HUP9901144A3 (en) 2001-04-28
DE122010000030I2 (de) 2012-06-21
BR9707556A (pt) 1999-07-27
NO2010015I2 (no) 2012-11-12
EP0881901A1 (fr) 1998-12-09
WO1997029753A1 (fr) 1997-08-21
NO2010015I1 (no) 2010-07-26
NZ331444A (en) 2001-04-27
NO983812L (no) 1998-10-09
CN1211922A (zh) 1999-03-24
FR2744918A1 (fr) 1997-08-22
KR19990087163A (ko) 1999-12-15
CZ292363B6 (cs) 2003-09-17
HK1017850A1 (en) 1999-12-03
IL125848A0 (en) 1999-04-11
NO983812D0 (no) 1998-08-19
SI0881901T1 (en) 2002-10-31
JPH11510818A (ja) 1999-09-21
ATE218870T1 (de) 2002-06-15
SK284285B6 (sk) 2005-01-03
FR2744918B1 (fr) 1998-05-07
DE122010000030I1 (de) 2010-10-21
CA2246289C (fr) 2003-12-16
DK0881901T3 (da) 2002-10-07
PT881901E (pt) 2002-09-30
DE69713287D1 (de) 2002-07-18
CN1116042C (zh) 2003-07-30
HU225036B1 (en) 2006-05-29
NO317747B1 (no) 2004-12-13
AU1884497A (en) 1997-09-02
DE69713287T2 (de) 2002-12-19
JP3662028B2 (ja) 2005-06-22
PL327923A1 (en) 1999-01-04
AU715655B2 (en) 2000-02-10
RU2184547C2 (ru) 2002-07-10
CA2246289A1 (fr) 1997-08-21
ES2176684T3 (es) 2002-12-01
EE9800247A (et) 1999-02-15
IL125848A (en) 2000-11-21
NO317747B3 (no) 2011-10-03
CZ249998A3 (cs) 1998-11-11
US5989578A (en) 1999-11-23
TR199801608T2 (xx) 1998-11-23

Similar Documents

Publication Publication Date Title
EE9800247A (et) Klopidogreeli ja tromboosivastast ühendit sisaldavad uued toimeainete kombinatsioonid
RS50485B (sr) Terapeutske kombinacije koje sadrže amplodipin i atorvastatin
FI973279A0 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
BR9607862A (pt) Composição farmacêutica filmogênica para administração transdérmica
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
DK1167354T3 (da) Racemisk huperzin A
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
PT862575E (pt) Novos derivados de geranilgeranilo processo para a sua preparacao e composicoes farmaceuticas relacionadas
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
IL110724A0 (en) Retroviral protease inhibitors, their preparation and pharmaceutical compositions containing them
FI963394A0 (fi) Yskää vastustava koostumus, joka sisältää yskää vastustavaa ainetta ja bentsydamiinia
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
SE9504662D0 (sv) New compounds
EE04347B1 (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, neid sisaldav ravim ja farmatseutiline kompositsioon
BG101849A (en) Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
FR2715564B1 (fr) Composition pharmaceutique contenant de la N-acétyl-cystéine.
IT9048605A0 (it) Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
ITMI930181A0 (it) Composizione farmaceutica contenente n-acetil-cisteina
ITMI911653A1 (it) Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
ITMI922832A1 (it) DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO.
AU8430791A (en) Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

AA1Y Spc filed

Free format text: PRODUCT NAME: DUOPLAVIN - KLOPIDROGREEL/ATSETUEUEL-SALITSUEUELHAPE; REG NO/DATE: C(2010)1817 15.03.2010

Spc suppl protection certif: C20100005

Filing date: 20100513

FG1Y Spc granted

Free format text: PRODUCT NAME: DUOPLAVIN - KLOPIDROGREEL/ATSETUEUEL-SALITSUEUELHAPE; REG NO/DATE: C(2010)1817 15.03.2010

Spc suppl protection certif: C20100005 00031

Filing date: 20100513

Extension date: 20220217

KB4A Valid patent at the end of a year

Effective date: 20101231

MC1Y Annulment of an spc

Spc suppl protection certif: 00031